Immuno-oncology

Product Indication Discovery PCC IND-enabling Phase I Phase II/III
CAN1012 Solid tumors US & China
CAN1012, PD-1 combo Solid tumors China
DVP-001 in partnership with NSCLC Breast HNSCC US & China

Small Molecule Drug Conjugate

Product Indication Discovery PCC IND-enabling Phase I Phase II/III
CAN2109 Solid tumors
CAN1100 Solid tumors
CAN1300 Solid tumors

ADC

Product Indication Discovery PCC IND-enabling Phase I Phase II/III
TLR ADC Tumors
StarLinker Tumor or autoimmune
Novel Target Solid tumors

Vaccine Adjuvant - External Collaboration

Product Indication Discovery PCC IND-enabling Phase I Phase II/III
CAN1012 COVID-19, HIV, Shingles

Collaborations

UbiVac
BaylorCollege
UniversityOfHongKong
ChilesResearchInstitute
KarolinskaInstitutet
GuangzhouInstitute
ImperialCollegeLondon
BBSS